Health: new vaccines approved to protect birds and pigs in Argentina

게시됨 2024년 12월 9일

Tridge 요약

Two new vaccines have been approved in Argentina for pigs to protect against Porcine Circovirus type 2a and 2b, and Mycoplasma hyopneumoniae, and a vaccine for chickens to guard against Marek's disease, infectious bursal disease, and Newcastle disease. These vaccines are crucial for preventing growth retardation and death in pigs, and immune response in chickens. The vaccines underwent authorization by the Undersecretariat of Agricultural and Forestry Production, the Coordination of Innovation and Biotechnology, and the National Advisory Commission on Agricultural Biotechnology, with compliance required to SENASA regulations before commercialization.
면책 조항: 위의 요약은 정보 제공 목적으로 Tridge 자체 학습 AI 모델에 의해 생성되었습니다.

원본 콘텐츠

These are two new vaccines against Porcine Circovirus type 2a and type 2b and respiratory disease due to Mycoplasma hyopneumoniae and a third that protects chickens against Marek's disease (MD), infectious bursal disease (Gumboro disease) and Newcastle disease (ND). Vaccines aimed at the pig sector represent a great protection for the productive sector since respiratory disease caused by Mycoplasma hyopneumoniae and porcine circovirus type 2 cause growth retardation. In the second case, death during the first months of the pig's life. The avian vaccine is based on genetically modified herpesvirus (from turkey), which acts by inoculating chickens in ovo or at day of age in order to produce an immune response for the three diseases mentioned. The respective authorizations were made through the Undersecretariat of Agricultural and Forestry Production, after the intervention of the Coordination of Innovation and Biotechnology and the National Advisory Commission on Agricultural ...
출처: Agromeat

더 깊이 있는 인사이트가 필요하신가요?

귀사의 비즈니스에 맞춤화된 상세한 시장 분석 정보를 받아보세요.
'쿠키 허용'을 클릭하면 통계 및 개인 선호도 산출을 위한 쿠키 제공에 동의하게 됩니다. 개인정보 보호정책에서 쿠키에 대한 자세한 내용을 확인할 수 있습니다.